These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 34477118)

  • 1. Prevalence and risk of residual viremia after ART in low- and middle-income countries: A cross-sectional study.
    Gatechompol S; Zheng L; Bao Y; Avihingsanon A; Kerr SJ; Kumarasamy N; Hakim JG; Maldarelli F; Gorelick RJ; Welker JL; Lifson JD; Hosseinipour MC; Eron JJ; Ruxrungtham K
    Medicine (Baltimore); 2021 Sep; 100(35):e26817. PubMed ID: 34477118
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytomegalovirus viremia in Thai HIV-infected patients on antiretroviral therapy: prevalence and associated mortality.
    Durier N; Ananworanich J; Apornpong T; Ubolyam S; Kerr SJ; Mahanontharit A; Ferradini L; Ruxrungtham K; Avihingsanon A
    Clin Infect Dis; 2013 Jul; 57(1):147-55. PubMed ID: 23511301
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors associated with unsuppressed viremia in women living with HIV on lifelong ART in the multi-country US-PEPFAR PROMOTE study: A cross-sectional analysis.
    Atuhaire P; Hanley S; Yende-Zuma N; Aizire J; Stranix-Chibanda L; Makanani B; Milala B; Cassim H; Taha T; Fowler MG
    PLoS One; 2019; 14(10):e0219415. PubMed ID: 31647806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of Male Sex and Obesity With Residual Plasma Human Immunodeficiency Virus 1 Viremia in Persons on Long-Term Antiretroviral Therapy.
    Cyktor JC; Bosch RJ; Mar H; Macatangay BJ; Collier AC; Hogg E; Godfrey C; Eron JJ; McMahon DK; Mellors JW; Gandhi RT;
    J Infect Dis; 2021 Feb; 223(3):462-470. PubMed ID: 32603416
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of raltegravir intensification on low-level residual viremia in HIV-infected patients on antiretroviral therapy: a randomized controlled trial.
    Gandhi RT; Zheng L; Bosch RJ; Chan ES; Margolis DM; Read S; Kallungal B; Palmer S; Medvik K; Lederman MM; Alatrakchi N; Jacobson JM; Wiegand A; Kearney M; Coffin JM; Mellors JW; Eron JJ;
    PLoS Med; 2010 Aug; 7(8):. PubMed ID: 20711481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of residual plasma viremia and intima-media thickness in antiretroviral-treated patients with controlled human immunodeficiency virus infection.
    Boyd A; Meynard JL; Morand-Joubert L; Michon A; Boccara F; Bastard JP; Samri A; Haddour N; Mallat Z; Capeau J; Desvarieux M; Girard PM;
    PLoS One; 2014; 9(11):e113876. PubMed ID: 25415323
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictors of residual viraemia in patients on long-term suppressive antiretroviral therapy.
    Zheng L; Bosch RJ; Chan ES; Read S; Kearney M; Margolis DM; Mellors JW; Eron JJ; Gandhi RT;
    Antivir Ther; 2013; 18(1):39-43. PubMed ID: 22914318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incomplete adherence to antiretroviral therapy is associated with higher levels of residual HIV-1 viremia.
    Li JZ; Gallien S; Ribaudo H; Heisey A; Bangsberg DR; Kuritzkes DR
    AIDS; 2014 Jan; 28(2):181-186. PubMed ID: 24361679
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Virological suppression and clinical management in response to viremia in South African HIV treatment program: A multicenter cohort study.
    Hermans LE; Carmona S; Nijhuis M; Tempelman HA; Richman DD; Moorhouse M; Grobbee DE; Venter WDF; Wensing AMJ
    PLoS Med; 2020 Feb; 17(2):e1003037. PubMed ID: 32097428
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantification of HIV-DNA and residual viremia in patients starting ART by droplet digital PCR: Their dynamic decay and correlations with immunological parameters and virological success.
    Alteri C; Scutari R; Stingone C; Maffongelli G; Brugneti M; Falasca F; Martini S; Bertoli A; Turriziani O; Sarmati L; Coppola N; Andreoni M; Santoro MM; Perno CF; Ceccherini-Silberstein F; Svicher V
    J Clin Virol; 2019 Aug; 117():61-67. PubMed ID: 31229934
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence and predictive value of intermittent viremia with combination hiv therapy.
    Havlir DV; Bassett R; Levitan D; Gilbert P; Tebas P; Collier AC; Hirsch MS; Ignacio C; Condra J; Günthard HF; Richman DD; Wong JK
    JAMA; 2001 Jul; 286(2):171-9. PubMed ID: 11448280
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Population prevalence of antiretroviral therapy sharing and its association with HIV viremia in rural Uganda: a cross-sectional population-based study.
    Kennedy CE; Feng X; Ssekubugu R; Rosen JG; Ssekasanvu J; Kigozi G; Serwadda D; Yeh PT; Kagaayi J; Quinn TC; Tobian AAR; Wawer MJ; Reynolds SJ; Chang LW; Grabowski MK; Nalugoda F
    J Int AIDS Soc; 2023 Sep; 26(9):e26135. PubMed ID: 37705364
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Full Viral Suppression, Low-Level Viremia, and Quantifiable Plasma HIV-RNA at the End of Pregnancy in HIV-Infected Women on Antiretroviral Treatment.
    Baroncelli S; Pirillo MF; Tamburrini E; Guaraldi G; Pinnetti C; Degli Antoni A; Galluzzo CM; Stentarelli C; Amici R; Floridia M
    AIDS Res Hum Retroviruses; 2015 Jul; 31(7):673-8. PubMed ID: 25769019
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Migration in Namibia and its association with HIV acquisition and treatment outcomes.
    Low A; Sachathep K; Rutherford G; Nitschke AM; Wolkon A; Banda K; Miller LA; Solmo C; Jackson K; Patel H; McCracken S; Findley S; Mutenda N
    PLoS One; 2021; 16(9):e0256865. PubMed ID: 34473757
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rate of and predicting factors for virologic failure in HIV-infected patients with persistent low-level viremia under antiretroviral therapy.
    Charuratananon S; Sungkanuparph S
    J Int Assoc Provid AIDS Care; 2015; 14(1):12-6. PubMed ID: 24651510
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Community viral load, antiretroviral therapy coverage, and HIV incidence in India: a cross-sectional, comparative study.
    Solomon SS; Mehta SH; McFall AM; Srikrishnan AK; Saravanan S; Laeyendecker O; Balakrishnan P; Celentano DD; Solomon S; Lucas GM
    Lancet HIV; 2016 Apr; 3(4):e183-90. PubMed ID: 27036994
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIV-1 DNA decay dynamics in blood during more than a decade of suppressive antiretroviral therapy.
    Besson GJ; Lalama CM; Bosch RJ; Gandhi RT; Bedison MA; Aga E; Riddler SA; McMahon DK; Hong F; Mellors JW
    Clin Infect Dis; 2014 Nov; 59(9):1312-21. PubMed ID: 25073894
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV-1 Very Low Level Viremia Is Associated with Virological Failure in Highly Active Antiretroviral Treatment-Treated Patients.
    Calcagno A; Motta I; Ghisetti V; Lo Re S; Allice T; Marinaro L; Milia MG; Tettoni MC; Trentini L; Orofino G; Salassa B; Di Perri G; Bonora S
    AIDS Res Hum Retroviruses; 2015 Oct; 31(10):999-1008. PubMed ID: 26165150
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Size, Composition, and Evolution of HIV DNA Populations during Early Antiretroviral Therapy and Intensification with Maraviroc.
    Chaillon A; Gianella S; Lada SM; Perez-Santiago J; Jordan P; Ignacio C; Karris M; Richman DD; Mehta SR; Little SJ; Wertheim JO; Smith DM
    J Virol; 2018 Feb; 92(3):. PubMed ID: 29142136
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Third-line antiretroviral therapy, including raltegravir (RAL), darunavir (DRV/r) and/or etravirine (ETR), is well tolerated and achieves durable virologic suppression over 144 weeks in resource-limited settings: ACTG A5288 strategy trial.
    Avihingsanon A; Hughes MD; Salata R; Godfrey C; McCarthy C; Mugyenyi P; Hogg E; Gross R; Cardoso SW; Bukuru A; Makanga M; Badal-Aesen S; Mave V; Ndege BW; Fontain SN; Samaneka W; Secours R; Van Schalkwyk M; Mngqibisa R; Mohapi L; Valencia J; Sugandhavesa P; Montalban E; Munyanga C; Chagomerana M; Santos BR; Kumarasamy N; Kanyama C; Schooley RT; Mellors JW; Wallis CL; Collier AC; Grinsztejn B;
    J Int AIDS Soc; 2022 Jun; 25(6):e25905. PubMed ID: 36039892
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.